Dashboard
Manage Tickers

XYLXylem Inc.

NYSE xylem.com


$ 135.20 $ 0.59 (0.44 %)    

Wednesday, 21-Aug-2024 10:42:04 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 484.31 $ 3.19 (0.66 %)
DIA $ 409.83 $ 0.60 (0.15 %)
SPY $ 562.10 $ 2.17 (0.39 %)
TLT $ 98.40 $ -0.28 (-0.28 %)
GLD $ 231.01 $ -0.65 (-0.28 %)
$ 134.15
$ 134.61
$ 134.93 x 212
$ 142.00 x 300
$ 134.16 - $ 135.23
$ 86.82 - $ 145.70
772,290
na
32.67B
$ 1.12
$ 42.71
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 10-31-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-24-2023 12-31-2022 10-K
8 11-01-2022 09-30-2022 10-Q
9 08-02-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-25-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 08-03-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 05-05-2020 03-31-2020 10-Q
19 02-28-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 02-22-2019 12-31-2018 10-K
24 10-30-2018 09-30-2018 10-Q
25 07-31-2018 06-30-2018 10-Q
26 05-01-2018 03-31-2018 10-Q
27 02-23-2018 12-31-2017 10-K
28 10-31-2017 09-30-2017 10-Q
29 08-01-2017 06-30-2017 10-Q
30 05-02-2017 03-31-2017 10-Q
31 02-23-2017 12-31-2016 10-K
32 11-01-2016 09-30-2016 10-Q
33 08-02-2016 06-30-2016 10-Q
34 05-03-2016 03-31-2016 10-Q
35 02-26-2016 12-31-2015 10-K
36 10-29-2015 09-30-2015 10-Q
37 07-30-2015 06-30-2015 10-Q
38 04-30-2015 03-31-2015 10-Q
39 02-26-2015 12-31-2014 10-K
40 10-28-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ubs-initiates-coverage-on-xylem-with-buy-rating-announces-price-target-of-165
UBS Initiates Coverage On Xylem with Buy R...
08/13/2024 10:56:48

UBS analyst Damian Karas initiates coverage on Xylem (NYSE:XYL) with a Buy rating and announces Price Target of $165.

beyond-the-numbers-11-analysts-discuss-xylem-stock
Beyond The Numbers: 11 Analysts Discuss Xy...
07/31/2024 19:00:59

baird-maintains-outperform-on-xylem-raises-price-target-to-170
Baird Maintains Outperform on Xylem, Raise...
07/31/2024 16:21:11

Baird analyst Michael Halloran maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $155 to $170.

stifel-maintains-buy-on-xylem-raises-price-target-to-172
Stifel Maintains Buy on Xylem, Raises Pric...
07/31/2024 15:56:21

Stifel analyst Nathan Jones maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $170 to $172.

rbc-capital-maintains-outperform-on-xylem-raises-price-target-to-163
RBC Capital Maintains Outperform on Xylem,...
07/31/2024 15:25:44

RBC Capital analyst Deane Dray maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $160 to $163.

xylems-water-wisdom-pays-off-q2-beats-estimates-outlook-upgraded
Xylem's Water Wisdom Pays Off: Q2 Beats Es...
07/30/2024 14:20:47

Xylem reported strong Q2 results, with revenue growth of 26%, adjusted EPS of $1.09, and raised its full-year guidance.

xylem-revises-fy24-revenue-guidance-to-855b-est-8561b-up-approximately-16-with-organic-revenue-growth-of-5---6-up-from-4---6
Xylem Revises FY24 Revenue Guidance To $8....
07/30/2024 10:59:49

 This represents an increase from the Company's previous full-year guidance of 15 to 16 percent on a reported basis and 4 t...

xylem-increases-fy24-adjusted-eps-guidance-from-410---425-to-418---428-est-422
Xylem Increases FY24 Adjusted EPS Guidance...
07/30/2024 10:57:11

xylem-q2-2024-adj-eps-109-beats-105-estimate-sales-2169b-beat-2145b-estimate
Xylem Q2 2024 Adj. EPS $1.09 Beats $1.05 E...
07/30/2024 10:56:02

Xylem (NYSE:XYL) reported quarterly earnings of $1.09 per share which beat the analyst consensus estimate of $1.05 by 3.81 perc...

stifel-maintains-buy-on-xylem-raises-price-target-to-170
Stifel Maintains Buy on Xylem, Raises Pric...
07/18/2024 15:58:05

Stifel analyst Nathan Jones maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $157 to $170.

xylem-commits-50m-to-expand-corporate-venture-investing-strategy-targets-startups-and-venture-capital-partners-addressing-climate-challenges-like-water-scarcity-quality-and-decarbonization
Xylem Commits $50M To Expand Corporate Ven...
07/10/2024 13:16:04

Core News & Articles
DuPont's Water Unit Attracts Interest From...
06/24/2024 18:55:58

- Bloomberg

peering-into-xylems-recent-short-interest
Peering Into Xylem's Recent Short Interest
06/13/2024 20:45:23

td-cowen-maintains-buy-on-xylem-raises-price-target-to-138
TD Cowen Maintains Buy on Xylem, Raises Pr...
06/06/2024 17:10:10

TD Cowen analyst Joseph Giordano maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $135 to $138.

tpu-deploys-xylems-ami-technology-to-enhance-operational-efficiency-and-customer-service-network-delivers-65m-daily-reads-for-frequent-billing-and-improved-response-times
TPU Deploys Xylem's AMI Technology To Enha...
06/06/2024 14:16:03

oppenheimer-maintains-outperform-on-xylem-raises-price-target-to-152
Oppenheimer Maintains Outperform on Xylem,...
05/31/2024 14:44:16

Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $147 to $152.

xylem-reiterates-2024-guidance-as-previously-provided-on-may-2-2024-introduces-long-term-financial-framework
Xylem Reiterates 2024 Guidance As Previous...
05/30/2024 11:11:36

Xylem's long-term financial framework anticipates annual organic revenue growth in the range of 4 percent to 6 percent, wit...

key-takeaways-from-xylem-analyst-ratings
Key Takeaways From Xylem Analyst Ratings
05/29/2024 16:00:46

argus-research-maintains-buy-on-xylem-raises-price-target-to-165
Argus Research Maintains Buy on Xylem, Rai...
05/29/2024 14:46:23

Argus Research analyst John Eade maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $146 to $165.

rbc-capital-maintains-outperform-on-xylem-raises-price-target-to-162
RBC Capital Maintains Outperform on Xylem,...
05/03/2024 16:31:17

RBC Capital analyst Deane Dray maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $157 to $162.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION